Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Clichy, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke
FrancePhase 2 Study of Lirafugratinib in Patients with Previously Treated Unresectable Advanced Solid Tumors with FGFR2 Fusion (Excluding Cholangiocarcinoma)
FranceSafety and Tolerability Study of Subcutaneous Pegtibatinase in Adults and Children with Classical Homocystinuria (Phase 1/2)
FranceImmunogenicity and safety of RSV A/B prefusion F protein vaccine versus RSV F glycoprotein recombinant adjuvanted vaccine in lung and stem cell transplant recipients
FranceStudy of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA
FrancePhase 2/3 study of telisotuzumab adizutecan with drug combination versus standard care in adults with first‑line metastatic pancreatic ductal adenocarcinoma
FranceEffect of Stopping Long‑Term Azithromycin in Stable Non‑Cystic Fibrosis Bronchiectasis Patients: A Randomized Controlled Trial
FrancePatient‑chosen treatment vs routine surgery for adult uncomplicated acute appendicitis: trial of amoxicillin‑clavulanic acid versus appendectomy
FranceAnakinra for patients with myeloproliferative neoplasms resistant to cytoreductive therapy: a study to improve treatment response
FranceDurvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer
FranceStudy of IDE849, IDE‑161 and durvalumab evaluating safety and efficacy in patients with DLL3‑positive tumors including small cell lung cancer
FranceSafety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on inflammatory bowel diseases and advanced treatment methods, including studies on Crohn's disease and ulcerative colitis using fecal microbiota transplantation as therapeutic approaches.
Research aims to improve patient outcomes through novel therapeutic interventions and treatment strategies.
Comprehensive studies on liver diseases and biliary tract conditions, investigating new treatments for cirrhosis, portal hypertension, and various forms of liver cancer.
Advanced therapeutic approaches combining immunotherapy and targeted treatments.
Groundbreaking research on pancreatic cancer and metabolic conditions, evaluating novel drug combinations and treatment protocols.
Focus on improving survival rates and treatment efficacy in advanced-stage diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
